Rebecca C Arend, MD, MSPH

Trials

Studies that name Rebecca C Arend, MD, MSPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:52 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04149275 · Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

  University of Alabama at Birmingham · withdrawn · Carcinosarcoma of Ovary, Carcinosarcoma of Uterus, Carcinosarcoma of Vagina · principal investigator
• Ph1
  NCT04149145 · Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer

  University of Alabama at Birmingham · withdrawn · Ovarian Cancer Recurrent · principal investigator
• N/A
  NCT03538665 · The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

  University of Alabama at Birmingham · recruiting · Endometrial Cancer, Endometrial Cancer Precursors, Ovarian Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cervical cancer and human papillomavirus (HPV) infection
  Z01CP010124 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MARK SCHIFFMAN · fiscal years 1996 to 2008
  Named on NCT03538665